Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

Mesa, RA ✉; Vannucchi, AM; Mead, A; Egyed, M [Egyed, Miklós (Hematológia), author] Somogy Megyei Kaposi Mór Oktató Kórház; Szoke, A; Suvorov, A; Jakucs, J; Perkins, A; Prasad, R; Mayer, J; Demeter, J [Demeter, Judit (Hematológia), author] I. Department of Internal Medicine (SU / FM / C); Ganly, P; Singer, JW; Zhou, H; Dean, JP; te, Boekhorst PA; Nangalia, J; Kiladjian, J-J; Harrison, CN